XML 38 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Operating expenses    
Research and development $ 6,334 $ 4,684
General and administrative 6,033 1,288
Total operating expenses 12,367 5,972
Financing expenses (income), net 111 (21)
Net loss for the year $ 12,478 $ 5,951
Basic and diluted loss per Ordinary Share [1] $ 0.060 $ 0.044
Weighted average number of Ordinary Shares outstanding, basic, and diluted [1] 207,468,650 136,755,498
[1] Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)